Drug interactions
Empagliflozin-linagliptin + Lonapegsomatropin
Severity: Moderate
Empagliflozin-linagliptin and Lonapegsomatropin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Growth hormone products can reduce insulin sensitivity and raise blood glucose, which may counteract the effect of empagliflozin and linagliptin. Patients with diabetes may need higher antidiabetic doses.
What this interaction means in plain words
Empagliflozin-linagliptin and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Empagliflozin-linagliptin belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.
Why it happens
Growth hormone-induced insulin resistance opposes the glucose-lowering action of the antidiabetic agents.
What to do
Monitor blood glucose closely when starting or adjusting lonapegsomatropin and adjust antidiabetic therapy as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Lonapegsomatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Other interactions of Lonapegsomatropin
Frequently asked questions
Can I take Empagliflozin-linagliptin with Lonapegsomatropin?
MediHelp rates the interaction as moderate. Empagliflozin-linagliptin and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone products can reduce insulin sensitivity and raise blood glucose, which may counteract the effect of empagliflozin and linagliptin. Patients with diabetes may need higher antidiabetic doses.
How serious is the interaction between Empagliflozin-linagliptin and Lonapegsomatropin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting or adjusting lonapegsomatropin and adjust antidiabetic therapy as needed.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
